Drug 'could help JIA sufferers' - The Press Association

Drug 'could help JIA sufferers' The Press Association The antibody drug tocilizumab, marketed as RoActemra, is at present only licensed for adults with moderate to severe rheumatoid arthritis. ... New hope for childhood arthritisPharmiWeb.com (press release) Drug boost in JIA study resultsPharmacy Europe Drug "could aid juvenile arthritis"Nursing in Practice all 7 news articles »

RoACTEMRA: New hope for children with systemic Juvenile Idiopathic Arthritis - Insciences Organisation

RoACTEMRA: New hope for children with systemic Juvenile Idiopathic Arthritis Insciences Organisation Pediatric Rheumatology Online Journal. 2005. Vol 3: 2 xi) Long-term efficacy of tocilizumab in rheumatoid arthritis for up to 3.5 years. Smolen J et al. ... RoACTEMRA: New hope for children with systemic Juvenile Idiopathic ArthritisChem.Info all 11 news articles »

Setting Long-term Health Priorities: The Three And Half Things You Need to Know - The Takeaway (blog)

Setting Long-term Health Priorities: The Three And Half Things You Need to Know The Takeaway (blog) Whether you're worried about high blood pressure or diabetes, rheumatoid arthritis or heart disease, there are just four steps you need to ...

Beverly A. Winings - The Free Lance-Star

Beverly A. Winings The Free Lance-Star In lieu of flowers, memorials may be made in her name to the Rheumatoid Arthritis Foundation, 3805 Cutshaw Ave. Suite 200, Richmond, Va. 23230. and more »